{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:19:17Z","timestamp":1777043957389,"version":"3.51.4"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,24]]},"DOI":"10.7759\/cureus.107642","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T13:51:51Z","timestamp":1777038711000},"source":"Crossref","is-referenced-by-count":0,"title":["Immune Checkpoint Inhibitor-Induced Scleroderma-Like Pulmonary Fibrosis in a Patient With Advanced Lung Cancer: A Case Report"],"prefix":"10.7759","author":[{"given":"Juan  O","family":"Rodriguez Padilla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yatin","family":"Kheti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Carrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila","family":"Villacreses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ph16020259","article-title":"Checkpoint inhibitor-associated scleroderma and scleroderma mimics","volume":"16","author":"Macklin M","year":"2023","unstructured":"Macklin M, Yadav S, Jan R, Reid P. Checkpoint inhibitor-associated scleroderma and scleroderma mimics. Pharmaceuticals (Basel). 2023, 16:10.3390\/ph16020259","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll DM","year":"2012","unstructured":"Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012, 12:252-64. 10.1038\/nrc3239","journal-title":"Nat Rev Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow MA","year":"2018","unstructured":"Postow MA, Sidlow R, Hellmann MD. Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med. 2018, 378:158-68. 10.1056\/NEJMra1703481","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-40618-3","article-title":"AJCC Cancer Staging Manual","author":"Amin MB","year":"2017","unstructured":"Amin MB, Edge SB, Greene FL, et al.. AJCC Cancer Staging Manual. Springer, Cham; 2017. 10.1007\/978-3-319-40618-3"},{"key":"ref5","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","unstructured":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013, 3.1-150.","journal-title":"Kidney Int Suppl"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/art.24586","article-title":"Anti-U11\/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis","volume":"61","author":"Fertig N","year":"2009","unstructured":"Fertig N, Domsic RT, Rodriguez-Reyna T, Kuwana M, Lucas M, Medsger TA Jr, Feghali-Bostwick CA. Anti-U11\/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis. Arthritis Rheum. 2009, 61:958-65. 10.1002\/art.24586","journal-title":"Arthritis Rheum"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead491","article-title":"Progressive pulmonary fibrosis and its impact on survival in systemic sclerosis-related interstitial lung disease","volume":"63","author":"Morrisroe K","year":"2024","unstructured":"Morrisroe K, Hansen D, Stevens W, et al.. Progressive pulmonary fibrosis and its impact on survival in systemic sclerosis-related interstitial lung disease. Rheumatology (Oxford). 2024, 63:1874-81. 10.1093\/rheumatology\/kead491","journal-title":"Rheumatology (Oxford)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2014.07.002","article-title":"Good outcome of interstitial lung disease in patients with scleroderma associated to anti-PM\/Scl antibody","volume":"44","author":"Guillen-Del Castillo A","year":"2014","unstructured":"Guillen-Del Castillo A, Pilar Sime\u00f3n-Aznar C, Fonollosa-Pla V, et al.. Good outcome of interstitial lung disease in patients with scleroderma associated to anti-PM\/Scl antibody. Semin Arthritis Rheum. 2014, 44:331-7. 10.1016\/j.semarthrit.2014.07.002","journal-title":"Semin Arthritis Rheum"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/36.3.360","article-title":"Interstitial lung fibrosis and rheumatic disorders in patients with hepatitis C virus infection","volume":"36","author":"Ferri C","year":"1997","unstructured":"Ferri C, La Civita L, Fazzi P, et al.. Interstitial lung fibrosis and rheumatic disorders in patients with hepatitis C virus infection. Br J Rheumatol. 1997, 36:360-5. 10.1093\/rheumatology\/36.3.360","journal-title":"Br J Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/467552-immune-checkpoint-inhibitor-induced-scleroderma-like-pulmonary-fibrosis-in-a-patient-with-advanced-lung-cancer-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T13:51:52Z","timestamp":1777038712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/467552-immune-checkpoint-inhibitor-induced-scleroderma-like-pulmonary-fibrosis-in-a-patient-with-advanced-lung-cancer-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.107642","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,24]]}}}